Study finds SARS-CoV-2 antibody kits have varying accuracy

By staff writers

September 25, 2020 -- Commercial SARS-CoV-2 antibody testing kits have a wide variation in sensitivity and specificity, according to a U.K. study published September 24 in PLOS Pathogens.

Researchers from Guy's and St. Thomas' National Health Service (NHS) Foundation Trust and King's College London developed their own sensitive and specific SARS-CoV-2 antibody test. They then used it to perform head-to-head comparisons of 10 commercial antibody test kits on an identical panel of 110 SARS-CoV-2-positive blood samples from patients admitted to hospitals with COVID-19, as well as 50 prepandemic negatives.

Specificity ranged from 82% to 100%, while sensitivity ranged from 60.9% to 87.3%. However, all tests gave the best results when used 20 days or more after the start of symptoms, when most yielded more than 95% sensitivity, according to the researchers.

The study's co-first authors included Blair Merrick of Guy's and St. Thomas' NHS Foundation Trust, as well as Rui Pedro Galão, PhD; Gilberto Betancor, PhD; Adrian Signell; and Suzanne Pickering, PhD, of King's College London.

The researchers also found that individuals with severe illness had higher antibody levels than those who were asymptomatic or had mild disease. In other results, lateral flow immunoassays called Accu-Tell, SureScreen, and Spring yielded the highest sensitivity at earlier time points, while still maintaining 98% or higher specificity.

"We found that some of the quick single-use kits (LFIAs) are as accurate as our sophisticated laboratory technologies," said senior author Jonathan Edgeworth, PhD, of Guy's and St. Thomas' NHS Foundation Trust in a statement. "Encouraged by these findings we are piloting LFIAs in the hospital to give doctors a quick reliable answer in a range of clinical settings."

Siemens collaborates with CDC, EC on SARS-CoV-2 assay standards
Siemens Healthineers said that it's collaborating with the U.S. Centers for Disease Control and Prevention (CDC) and the Joint Research Centre of the...
Avero expands its COVID-19 testing lineup
Avero Diagnostics added the Roche Elecsys anti-SARS-CoV-2 antibody test to its COVID-19 testing portfolio. The serological test is available now and complements...
Beckman Coulter releases COVID-19 antibody test
Beckman Coulter has released its Access SARS-CoV-2 Immunoglobulin M assay, a new antibody test for the novel coronavirus. The assay targets antibodies...
Data-sharing platform could help planning for future pandemics
In response to the global pandemic, the authors of a new paper are calling for a robust centralized platform to improve international data sharing among...
A look at how COVID-19 testing varies by world region
While demand for COVID-19 testing has grown globally, the testing situation differs from region to region, writes Justin Saeks, an analyst with market...

Copyright © 2020

Last Updated np 9/29/2020 4:47:10 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current